Drug Type Synthetic peptide |
Synonyms |
Target |
Mechanism ADMR agonists(Adrenomedullin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Himuka AM Pharma Corp.Startup |
Active Organization Himuka AM Pharma Corp.Startup |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colitis, Ulcerative | Phase 1 | AU | Himuka AM Pharma Corp.Startup | 11 Nov 2021 |
Crohn Disease | Phase 1 | AU | Himuka AM Pharma Corp.Startup | 11 Nov 2021 |